+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Polycystic Ovarian Syndrome Treatment Market Size, Share & Trends Analysis Report by Drug Class (Oral Contraceptives, Antiandrogens, Insulin-sensitizing Agent, Antidepressant, Anti-obesity), Surgery, Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 5998934
The Polycystic Ovarian Syndrome Treatment Market was valued at USD 4.79 billion in 2024, and is projected to reach USD 6.99 billion by 2030, rising at a CAGR of 6.60%. According to the Centers of Disease Control & Prevention (CDC), Polycystic Ovary Syndrome (PCOS) is the most common cause of female infertility. Approximately 6% to 12% women of reproductive age suffer from PCOS in the U. S. Moreover, progression of this condition can lead to metabolic abnormalities, which may result in development of type 2 diabetes, if the syndrome is not treated on time. The severity of the disorder increases the risk of developing uterine and endometrial cancers in patients. Thus, early diagnosis and effective treatment are significant for successful recovery.

Presently, no specific drug is commercially available for this condition. Thus, treating symptoms is the prime aim of the treatment regimen. Owing to the various symptoms associated with this syndrome, a range of drug class/combinations is used in the treatment. Therefore, market leaders are focusing on developing a specific drug/treatment to cure the root cause of this disease. AstraZeneca is one of the leaders involved in developing such a drug.

Polycystic Ovarian Syndrome Treatment Market Report Highlights

  • Based on drug class, the insulin-sensitizing agents dominated the market and accounted for a share of 36.0% in 2024.
  • By surgery, the ovarian wedge resection segment is expected to grow at a significant CAGR over the forecast period.
  • Based on the distribution channel, the online providers segment is expected to register the fastest CAGR during the forecast period.
  • Asia-Pacific’s polycystic ovarian syndrome treatment market is estimated to register the fastest CAGR over the forecast period.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Polycystic Ovarian Syndrome Treatment Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Billion)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Polycystic Ovarian Syndrome Treatment Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Polycystic Ovarian Syndrome Treatment Market: Drug Class Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Polycystic Ovarian Syndrome Treatment Market:, Drug Class Movement Analysis, 2024 & 2030 (USD Billion)
4.3. Oral Contraceptives
4.3.1. Oral Contraceptives Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.4. Antiandrogens
4.4.1. Antiandrogens Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.5. Insulin-sensitizing Agent
4.5.1. Insulin-sensitizing Agent Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.6. Antidepressant
4.6.1. Antidepressant Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
4.7. Anti-obesity
4.7.1. Anti-obesity Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 5. Polycystic Ovarian Syndrome Treatment Market: Surgery Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Polycystic Ovarian Syndrome Treatment Market: Surgery Movement Analysis, 2024 & 2030 (USD Billion)
5.3. Ovarian Wedge Resection
5.3.1. Ovarian Wedge Resection Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
5.4. Laparoscopic Ovarian Drilling
5.4.1. Laparoscopic Ovarian Drilling Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 6. Polycystic Ovarian Syndrome Treatment Market: Distribution Channel Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Polycystic Ovarian Syndrome Treatment Market: Distribution Channel Movement Analysis, 2024 & 2030 (USD Billion)
6.3. Hospital Pharmacy
6.3.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.4. Drug Store & Retail Pharmacy
6.4.1. Drug Store & Retail Pharmacy Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
6.5. Online Providers
6.5.1. Online Providers Market Revenue Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 7. Polycystic Ovarian Syndrome Treatment Market: Regional Estimates & Trend Analysis
7.1. Polycystic Ovarian Syndrome Treatment Market Share, By Region, 2024 & 2030 (USD Billion)
7.2. North America
7.2.1. North America Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.2.2. U.S.
7.2.3. U.S. Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.2.4. Canada
7.2.4.1. Canada Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.2.5. Mexico
7.2.5.1. Mexico Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.3. Europe
7.3.1. Europe Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.3.2. UK
7.3.2.1. UK Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.3.3. Germany
7.3.3.1. Germany Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.3.4. France
7.3.4.1. France Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.4.2. China
7.4.2.1. China Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.4.3. Japan
7.4.3.1. Japan Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.4.4. India
7.4.4.1. India Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.4.5. South Korea
7.4.5.1. South Korea Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.4.6. Australia
7.4.6.1. Australia Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5. Latin America
7.5.1. Latin America Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.5.2. Brazil
7.5.2.1. Brazil Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.3. UAE
7.6.3.1. UAE Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
7.6.4. South Africa
7.6.4.1. South Africa Polycystic Ovarian Syndrome Treatment Market Estimates and Forecasts, 2018-2030 (USD Billion)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. AstraZeneca
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Bayer AG
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Merck KGaA.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Abbott
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Pfizer, Inc
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Sanofi
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Bristol Myers Squibb Company
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. Teva Pharmaceutical Industries Ltd
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Novartis AG
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives
8.4.10. Ferring B.V.
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Leading Market Players Anticipated to Witness Highest Growth
Table 4. Global polycystic ovarian syndrome treatment market, By Region, 2018-2030 (USD Billion)
Table 5. Global polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 6. Global polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 7. Global polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 8. North America polycystic ovarian syndrome treatment market, By Country, 2018-2030 (USD Billion)
Table 9. North America polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 10. North America polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 11. North America polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 12. U.S. polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 13. U.S. polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 14. U.S. polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 15. Canada polycystic ovarian syndrome treatment market, By, By Drug Class, 2018-2030 (USD Billion)
Table 16. Canada polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 17. Canada polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 18. Mexico polycystic ovarian syndrome treatment market, By, By Drug Class, 2018-2030 (USD Billion)
Table 19. Mexico polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 20. Mexico polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 21. Europe polycystic ovarian syndrome treatment market, By Country, 2018-2030 (USD Billion)
Table 22. Europe polycystic ovarian syndrome treatment market, By, By Drug Class, 2018-2030 (USD Billion)
Table 23. Europe polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 24. Europe polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 25. UK polycystic ovarian syndrome treatment market, By, By Drug Class, 2018-2030 (USD Billion)
Table 26. UK polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 27. UK polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 28. Germany polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 29. Germany polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 30. Germany polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 31. France polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 32. France polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 33. France polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 34. Italy polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 35. Italy polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 36. Italy polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 37. Spain polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 38. Spain polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 39. Spain polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 40. Denmark polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 41. Denmark polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 42. Denmark polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 43. Sweden polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 44. Sweden polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 45. Sweden polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 46. Norway polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 47. Norway polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 48. Norway polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 49. Asia Pacific polycystic ovarian syndrome treatment market, By Country, 2018-2030 (USD Billion)
Table 50. Asia Pacific polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 51. Asia Pacific polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 52. Asia Pacific polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 53. Japan polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 54. Japan polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 55. Japan polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 56. China polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 57. China polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 58. China polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 59. India polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 60. India polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 61. India polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 62. South Korea polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 63. South Korea polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 64. South Korea polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 65. Australia polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 66. Australia polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 67. Australia polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 68. Thailand polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 69. Thailand polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 70. Thailand polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 71. Latin America polycystic ovarian syndrome treatment market, By Country, 2018-2030 (USD Billion)
Table 72. Latin America polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 73. Latin America polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 74. Latin America polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 75. Brazil polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 76. Brazil polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 77. Brazil polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 78. Argentina polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 79. Argentina polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 80. Argentina polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 81. Middle East and Africa polycystic ovarian syndrome treatment market, By Country, 2018-2030 (USD Billion)
Table 82. Middle East and Africa polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 83. Middle East and Africa polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 84. Middle East & Africa polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 85. South Africa polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 86. South Africa polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 87. South Africa polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 88. Saudi Arabia polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 89. Saudi Arabia polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 90. Saudi Arabia polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 91. UAE polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 92. UAE polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 93. UAE polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
Table 94. Kuwait polycystic ovarian syndrome treatment market, By Drug Class, 2018-2030 (USD Billion)
Table 95. Kuwait polycystic ovarian syndrome treatment market, By Surgery, 2018-2030 (USD Billion)
Table 96. Kuwait polycystic ovarian syndrome treatment market, By Distribution Channel, 2018-2030 (USD Billion)
List of Figures
Figure 1 Polycystic ovarian syndrome treatment market segment scope and defination
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Market outlook (2024)
Figure 10 Strategy framework
Figure 11 Market driver relevance analysis (Current & future impact)
Figure 12 Market restraint relevance analysis (Current & future impact)
Figure 13 Penetration & growth prospect mapping
Figure 14 Porter’s five forces analysis
Figure 15 PESTLE analysis
Figure 16 Polycystic ovarian syndrome treatment market:, By Drug Class movement analysis
Figure 17 Polycystic ovarian syndrome treatment market:, By Drug Class segment dashboard
Figure 18 Polycystic ovarian syndrome treatment market, By Drug Class outlook: Key takeaways
Figure 19 Luminometric Polycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 20 Enzymatic Polycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 21 Bioluminescence Resonance Energy Transfer (BRET) Polycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 22 Cell-based Polycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 23 Anti-obesity Polycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 24 Polycystic ovarian syndrome treatment market: Surgery movement analysis
Figure 25 Polycystic ovarian syndrome treatment market Surgery outlook: Key takeaways
Figure 26 Ovarian Wedge Resection Polycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 27 Laparoscopic Ovarian Drilling Polycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 28 Polycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 29 Food Safety and Quality TestingPolycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 30 Other Polycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 31 Polycystic ovarian syndrome treatment market: Distribution Channel movement analysis
Figure 32 Polycystic ovarian syndrome treatment market Distribution Channel outlook: Key takeaways
Figure 33 Hospital Pharmacy Polycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 34 Drug Store & Retail Pharmacy Polycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 35 Online Providers Polycystic ovarian syndrome treatment market estimates and forecast, 2018-2030 (USD Billion)
Figure 36 Regional outlook, 2024 & 2030
Figure 37 Regional market dashboard
Figure 38 Regional market place: Key takeaways
Figure 39 North America polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 40 U.S. polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 41 Canada polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 42 Mexico polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 43 Europe polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 44 UK polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 45 Germany polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 46 Spain polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 47 France polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 48 Italy implantable Market, 2018-2030 (USD Billion)
Figure 49 Denmark polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 50 Sweden polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 51 Norway polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 52 Asia Pacific polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 53 Japan polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 54 China polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 55 India polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 56 South Korea polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 57 Australia polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 58 Thailand polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 59 Latin America polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 60 Brazil polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 61 Argentina polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 62 MEA polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 63 South Africa polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 64 Saudi Arabia polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 65 UAE polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 66 Kuwait polycystic ovarian syndrome treatment market, 2018-2030 (USD Billion)
Figure 67 Heat map analysis
Figure 68 Market differentiators

Companies Mentioned

The major companies featured in this Polycystic Ovarian Syndrome Treatment market report include:
  • AstraZeneca
  • Bayer AG
  • Merck KGaA
  • Abbott
  • Pfizer, Inc
  • Sanofi
  • Bristol Myers Squibb Company
  • Teva Pharmaceutical Industries Ltd
  • Novartis AG
  • Ferring B.V.

Table Information